Related Experiment Video
Updated: Oct 12, 2025
Immuno-fluorescence Assay of Leptospiral Surface-exposed Proteins
Published on: July 1, 2011
In silico screening and epitope mapping of leptospiral outer membrane protein-Lsa46
Junaida M Ibrahim1, Shanitha A1, Achuthsankar S Nair1
1Department of Computational Biology & Bioinformatics, University of Kerala, Thiruvananthapuram, Kerala, India.
Abstract:
Leptospirosis is one of the neglected diseases caused by the spirochete, Leptospira interrogans. Leptospiral surface adhesion (Lsa) proteins are surface exposed outer membrane proteins present in the pathogen. It acts as laminin and plasminogen binding proteins which enable them to infect host cells. The major target for the development of vaccine in the current era focuses on surface exposed outer membrane proteins, as they can induce strong and fast immune response in hosts. Therefore, the present study mapped the potential epitopes of the Leptospiral outer membrane proteins, mainly the surface adhesion proteins. Protein sequence analysis of Lsa proteins was done by in silico methods. The primary protein sequence analysis revealed Lsa46 as a suitable target which can be a potent Leptospiral vaccine candidate. Its structure was modelled by threading based method in I-TASSER server and validated by Ramachandran plot. The predicted epitope's interactions with human IgG, IgM(Fab) and T-cell receptor TCR(αβ) were performed by molecular docking studies using Biovia Discovery studio 2018. One of the predicted B-cell epitopes and the IgG showed desirable binding interactions, while four of the predicted B-cell epitopes and T-cell epitopes showed desirable binding interactions with IgM and TCR respectively. The molecular dynamic simulation studies carried out with the molecular docked complexes gave minimized energies indicating stable interactions. The structural analysis of the entire simulated complex showed a stable nature except for one of the Epitope-IgM complex. Further the binding free energy calculation of eight receptor-ligand complex predicted them energetically stable. The results of the study help in elucidating the structural and functional characterization of Lsa46 for epitope-based vaccine design.Communicated by Ramaswamy H. Sarma.
Insights
Researchers identified Lsa46, a Leptospira surface adhesion protein, as a promising vaccine candidate. Computational analysis revealed specific epitopes on Lsa46 that interact with human immune molecules, paving the way for effective leptospirosis vaccines.
Area of Science:
- Microbiology and Immunology
- Computational Biology
- Vaccine Development
Background:
- Leptospirosis, a neglected disease caused by *Leptospira interrogans*, is a significant global health concern.
- Leptospiral surface adhesion (Lsa) proteins are crucial outer membrane proteins involved in host cell infection.
- Surface-exposed proteins are primary targets for vaccine development due to their immunogenicity.
Purpose of the Study:
- To identify and characterize potential epitopes on Leptospiral outer membrane proteins, specifically Lsa proteins, for vaccine design.
- To evaluate Lsa46 as a potential vaccine candidate against leptospirosis.
- To elucidate the structural and functional properties of Lsa46 relevant to epitope-based vaccine strategies.
Main Methods:
- *In silico* protein sequence analysis of Lsa proteins.
- Structure modeling of Lsa46 using the I-TASSER server and validation via Ramachandran plot.
- Molecular docking studies to predict interactions between Lsa46 epitopes and human immune molecules (IgG, IgM, TCR).
- Molecular dynamic simulations and binding free energy calculations to assess interaction stability.
Main Results:
- Lsa46 was identified as a suitable vaccine candidate based on protein sequence analysis.
- Specific B-cell and T-cell epitopes on Lsa46 demonstrated favorable binding interactions with human IgG, IgM, and TCR.
- Molecular dynamics simulations and binding free energy calculations confirmed the stable interactions of most simulated complexes, indicating potential immunogenicity.
Conclusions:
- Lsa46 is a promising candidate for epitope-based leptospirosis vaccine development.
- The identified epitopes on Lsa46 show potential for inducing a robust immune response.
- Further structural and functional characterization of Lsa46 will aid in designing effective vaccines against leptospirosis.
